Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diagnosing model diagnostics.

M O Karlsson1, R M Savic

  • 1Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden. mats.karlsson@farmbio.uu.se

Clinical Pharmacology and Therapeutics
|June 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A comparison of clinical development pathways to advance tuberculosis regimen development.

BMC infectious diseases·2022
Same author

Responding to the post-pandemic crisis: post-exposure prophylaxis for TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Clinical standards for the dosing and management of TB drugs.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2021
Same author

A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials.

Trials·2021
Same author

Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020

Model-based analyses in clinical trials require accurate models for reliable conclusions. Evaluating the diagnostics used to assess model adequacy is crucial to avoid misinterpreting results and ensure trustworthy scientific findings.

Area of Science:

  • Pharmacometrics
  • Clinical Trial Analysis
  • Statistical Modeling

Background:

  • Model-based analyses are integral to interpreting clinical trial data.
  • The reliability of these analyses hinges on the adequacy of the underlying statistical models.
  • Existing diagnostics for assessing model adequacy have limitations that are not widely understood.

Purpose of the Study:

  • To highlight the shortcomings of traditional diagnostics for model adequacy in clinical trials.
  • To emphasize the need for a thorough understanding of diagnostic properties.
  • To advocate for the development and critical evaluation of new diagnostics.

Main Methods:

  • Review of traditional diagnostic tools for model adequacy in statistical modeling.
  • Analysis of the properties and limitations of existing diagnostics.

Related Experiment Videos

  • Discussion on the implications for model selection and interpretation in clinical research.

    • Main Results:

    • Traditional diagnostics for model adequacy often lack comprehensive documentation of their limitations.
    • Misapplication or misunderstanding of these diagnostics can lead to incorrect conclusions.
    • There is a significant risk of accepting inadequate models or rejecting adequate ones.

    Conclusions:

    • A critical evaluation of available diagnostics for model adequacy is essential.
    • Understanding diagnostic properties prevents erroneous model acceptance or rejection.
    • Improved diagnostics are needed to ensure the robustness of model-based clinical trial conclusions.